Hepatitis C virus inhibitors
    5.
    发明授权
    Hepatitis C virus inhibitors 有权
    丙型肝炎病毒抑制剂

    公开(公告)号:US08618153B2

    公开(公告)日:2013-12-31

    申请号:US13611708

    申请日:2012-09-12

    摘要: This disclosure concerns novel compounds of Formula (I) or as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.

    摘要翻译: 本公开涉及式(I)的新化合物或说明书中定义的和包含这些新化合物的组合物。 这些化合物是有用的抗病毒剂,特别是抑制由丙型肝炎病毒(HCV)编码的NS5A蛋白的功能。 因此,本公开还涉及通过使用这些新化合物或包含这些新化合物的组合物治疗HCV相关疾病或病症的方法。